The stimulatory effect of SNHG1 on IGF-1, though not yet described in cancer models, may be highly relevant since SNHG1 has been extensively reported to be upregulated in a variety of cancers including colorectal, lung, prostate and bone cancers, with effects on cell proliferation, migration and invasion [77]. Here, SNHG1 is linked to bone cancer.